Effectiveness and safety of omalizumab for chronic spontaneous urticaria during pregnancy: A systematic review (Risk of bias-JBI critical appraisal tools-Included studies extracted data-Supplementary material)
Published: 5 June 2025| Version 3 | DOI: 10.17632/59d9ghb7nm.3
Contributor:
Ioannis-Alexios KoumprentziotisDescription
Risk of bias evaluation using the JBI critical appraisal tools based on each eligible study type.
Files
Institutions
- National and Kapodistrian University of Athens
Categories
Pregnancy, Biologic Agent, Systematic Review, Urticaria